Insight Wealth Strategies’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,781
Closed -$3.81M 190
2026
Q1
$3.81M Buy
6,781
+60
+0.9% +$38.5K 0.43% 77
2025
Q4
$4.55M Sell
6,721
-1,819
-21% -$1.24M 0.52% 62
2025
Q3
$5.46M Sell
8,540
-120
-1% -$72.8K 0.64% 42
2025
Q2
$4.7M Sell
8,660
-1,332
-13% -$637K 0.59% 43
2025
Q1
$4.2M Sell
9,992
-104
-1% -$45.2K 0.57% 50
2024
Q4
$4.17M Buy
10,096
+7,041
+230% +$3.09M 0.56% 51
2024
Q3
$1.54M Buy
3,055
+107
+4% +$52K 0.2% 108
2024
Q2
$1.44M Buy
2,948
+165
+6% +$82.8K 0.2% 109
2024
Q1
$1.5M Buy
2,783
+29
+1% +$15.8K 0.22% 112
2023
Q4
$1.53M Buy
2,754
+60
+2% +$28.2K 0.25% 96
2023
Q3
$1.18M Buy
2,694
+92
+4% +$45.9K 0.23% 92
2023
Q2
$1.31M Sell
2,602
-28
-1% -$13.4K 0.25% 78
2023
Q1
$1.32M Sell
2,630
-39
-1% -$18.7K 0.26% 74
2022
Q4
$1.09M Buy
2,669
+189
+8% +$73.4K 0.21% 88
2022
Q3
$870K Hold
2,480
0.16% 100
2022
Q2
$870K Sell
2,480
-37
-1% -$15.1K 0.16% 100
2022
Q1
$1.38M Buy
2,517
+296
+13% +$156K 0.2% 85
2021
Q4
$1.46M Buy
+2,221
New +$1.39M 0.21% 75

Other funds holding IDXX

Insight Wealth Strategies's IDXX Position: Q2 2026 in Review

Insight Wealth Strategies sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 6,781 shares — an estimated $3.81M sold.

Insight Wealth Strategies first reported a position in IDXX in Q4 2021 and held it in 18 quarters. The position peaked at $5.46M in Q3 2025. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Insight Wealth Strategies reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Insight Wealth Strategies sold 6,781 Idexx Laboratories shares in Q2 2026, an estimated $3.81M.
  • Insight Wealth Strategies first reported a position in Idexx Laboratories in Q4 2021 and held it in 18 quarters.
  • Insight Wealth Strategies's Idexx Laboratories position peaked at $5.46M in Q3 2025.
  • 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Insight Wealth Strategies's 13F filing for Q2 2026, filed 10 Jul 2026.